• 1
    Blatchford O, Davidson LA, Murray WR, et al. Acute upper gastrointestinal hemorrhage in west of Scotland: case ascertainment study. BMJ 1997; 315: 5104.
  • 2
    Vreeburg EM, Snel P, de Bruijne JW, et al. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis and clinical outcome. Am J Gastroenterol 1997; 92: 23643.
  • 3
    Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90: 20610.
  • 4
    Targownik LW, Nabalamba A. Trends in management and outcomes of acute non-variceal upper gastrointestinal bleeding: 1993–2003. Clin Gastroenterol Hepatol 2006; 4: 145966.
  • 5
    Rockall TA, Logan RF, Devlin HB, et al. Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Hemorrhage. BMJ 1995; 311: 2226.
  • 6
    Christensen A, Bousfield R, Christiansen J. Incidence of perforated and bleeding peptic ulcers before and after the introduction of H2-receptor antagonists. Ann Surg 1988; 207: 46.
  • 7
    Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology 1992; 102: 13948.
  • 8
    Marmo R, Rotondano G, Piscopo R, Bianco MA, D'Angella R, Cipolletta L. Dual therapy versus monotherapy in the endoscopic treatment of highrisk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 2007; 102: 27989.
    Direct Link:
  • 9
    Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of bleeding non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 2007; 56: 136472.
  • 10
    Green FW, Kaplan MM, Curtis LE, Levine PH. Effects of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastro duodenal mucosal haemorrhage. Gastroenterology 1978; 74: 3843.
  • 11
    Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 3106.
  • 12
    Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998; 158: 548.
  • 13
    Sung JJ, Barkun A, Kuipers EJ, et al. Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150: 45564.
  • 14
    Leontiadia GI, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2006; (1): CD002094.
  • 15
    Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Meta-analysis proton pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005; 21: 67786.
  • 16
    Laine L, Shah A, Bemanian S. Intragastric PH with oral vs. intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers. Gastroenterology 2008; 134: 183641.
  • 17
    Javid G, Zargar SA, U-Saif R, et al. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer. J Gastroenterol Hepatol 2009; 24: 123643.
  • 18
    Jae YJ, Kwang RJ, Young H, et al. A comparison of the effect of high-dose oral and intravenous proton pump inhibitor on the prevention of rebleeding after endoscopic treatment of bleeding peptic ulcers. Korean J Gastrointest Endosc 2006; 22: 611.
  • 19
    Yilmaz S, Bayan K, Tuzun Y, Dursun M, Canoruc F. A head to head comparison of oral vs intravenous omeprazole for patients with bleeding peptic ulcers with a clean base, flat spots and adherent clots. World J Gastroenterol 2006; 12: 783743.
  • 20
    Bajaj JS, Dua KS, Hanson K, Presberg K. Prospective, randomized trial comparing effect of oral versus intravenous pantoprazole on rebleeding after nonvariceal upper gastrointestinal bleeding: a pilot study. Dig Dis Sci 2007; 52: 21904.
  • 21
    Tsai JJ, Hsu YC, Perng CL, Lin HJ. Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection. Br J Clin Pharmacol 2008; 67: 32632.
  • 22
    Mostaghi AA, Hashemi SA, Heydari ST. Comparison of oral and intravenous proton pump inhibitor on patients with high risk bleeding peptic ulcers: a prospective, randomized, controlled clinical trial. Iran Red Crescent Med J 2011; 13: 45863.
  • 23
    Yen HH, Yang CW, Su WW, et al. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy. BMC Gastroenterol 2012; 12: 66.
  • 24
    Higgins JP, Altman DG, Gotzsche DM, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
  • 25
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 112.
  • 26
    Review Manager (RevMan) (Computer program) Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
  • 27
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 17788.
  • 28
    Liu N, Liu L, Zhang H, et al. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding. J Gastroenterol Hepatol 2012; 27: 14739.
  • 29
    Hartmann M, Ehrlich A, Fuder H, et al. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Aliment Pharmacol Ther 1998; 12: 102732.
  • 30
    Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding. Scand J Gastroenterol 2001; 36: 13328.
  • 31
    Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 71727.
  • 32
    Chung IK, Kim EJ, Lee MS, et al. Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy 2001; 33: 96975.
  • 33
    Poole P. Pantoprazole. Am J Health Syst Pharm 2001; 58: 9991008.